Michael Dilworth and Dr. Anthony Sabatelli of Dilworth IP will be attending the 2015 BIO National Convention (BIO 2015) in Philadelphia June 15th-19th.  They will be joined by several other organizations and businesses from Connecticut’s life science community showcasing the state’s leadership in the biosciences.  The Firm is one of several sponsors of the Connecticut Booth along with Yale University, the University of Connecticut, The Jackson Laboratory, the Town of Branford, CT, and CURE (CT United for Research Excellence).  In addition, support for the booth will be provided by several organizations active in promoting innovation and entrepreneurship for Connecticut’s bioscience community including the Connecticut Department of Economic and Community Development and Connecticut Innovations (CI), which provides financial support to Connecticut-based start-ups.

The Connecticut booth will be a hub for the many companies and innovators from the state, where raffles and materials will be available and several presentations will be made. Companies that will be present include: LambdaVision, CURE/China Portal, MultiClonal Therapeutics, AlloMek Therapeutics, Lipid Genomics, Aria Neurosciences, BIOARRAY Therapeutics, Arvinas, GestVision, HLK Pharma, CaroGen Corporation, Intensity Therapeutics, Vesselon, Mount Sinai Genetics Testing Laboratory, Dura Biotech, Isoplexis, Fluid-Screen, AxioMx, UConn TIP, and CURE Innovation Commons.

All are invited to stop by the booth (#4263), located in The Discovery Zone, Hall A-E of the venue, open from 9:30 am Tuesay, June 16, through 4:30 pm Thursday, June 18. (Click here for map.)

More information about the Connecticut BIO booth can be found in CURE’s press release.

 

Dilworth IP is an intellectual property and business law firm providing legal services in the areas of patent and trademark prosecution, opinions, agreements and litigation in the chemical, biotech, pharmaceutical, medical device, material science, consumer products, electronics, software, and semiconductor industries. We’ve been in the lab. Whether your invention is a controlled-release pharmaceutical, a fuel cell, or a new polyolefin catalyst, our attorneys will speak your language and listen well. We’ll quickly grasp nuances of your complex technology and capture the IP protection you deserve. To learn more about the firm, please visit www.dilworthip.com.